ResearcherRenmin Hospital of Wuhan UniversityNo recent work listed

Weixing Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3854-0083; OpenAlex author ID A5100739968. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

Upregulation of LncRNA PVT1 Facilitates Pancreatic Ductal Adenocarcinoma Cell Progression and Glycolysis by Regulating MiR-519d-3p and HIF-1A. Last author DOI 10.7150/jca.37959 ↗
LINC00052 functions as a tumor suppressor through negatively modulating miR-330-3p in pancreatic cancer. Co-author DOI 10.1002/jcp.28209 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Junwei Sun · 1 shared paper, 2020 · strength 0.15
- Paper Upregulation of LncRNA PVT1 Facilitates Pancreatic Ductal Adenocarcinoma Cell Progression and Glycolysis by Regulating … DOI 10.7150/jca.37959 ↗
Xingcheng Xiong · 1 shared paper, 2019 · strength 0.12
- Paper LINC00052 functions as a tumor suppressor through negatively modulating miR-330-3p in pancreatic cancer. DOI 10.1002/jcp.28209 ↗
Jing Tao · 1 shared paper, 2019 · strength 0.12
- Paper LINC00052 functions as a tumor suppressor through negatively modulating miR-330-3p in pancreatic cancer. DOI 10.1002/jcp.28209 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.